相关实验视频

Updated: Jun 18, 2025

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

多种癌症早期检测的技术和未来

Danny A Milner^1,2, Jochen K Lennerz³

¹Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.

Life (Basel, Switzerland)

|July 27, 2024

概括

综合基因组,转录基因组,蛋白质基因组和代谢基因组数据的多组学方法为早期癌症检测提供了更高的灵敏度和特异性. 这一进步有望通过先进的诊断来改善患者的治疗结果和个性化癌症护理.

科学领域:

瘤学和生物信息学
生物医学诊断生物医学诊断

背景情况:

癌症对全球健康造成重大负担,患病率和死亡率很高.
目前的早期癌症检测方法往往缺乏足够的灵敏度和特异性.
改进的诊断工具对于更好的患者结果至关重要.

研究的目的:

探索多omics方法的潜力,以提高早期癌症检测.
为了应对挑战,并强调整合多样化的OMIC数据的好处.
为了展示多omics如何可以彻底改变癌症诊断.

主要方法:

整合多omics数据:基因组,转录组,蛋白质组和代谢组数据.
分析数据整合的挑战和好处.
在其他科学领域成功的多学科应用程序的审查.

主要成果:

多omics集成可以显著提高早期癌症的诊断灵敏度和特异性.
成功的例子证明了多组学在复杂的生物系统中的实用性.
这种方法有望为更准确和及时的癌症鉴定提供希望.

结论:

多omics方法代表了早期癌症检测的变革潜力.
这些综合方法可以带来更好的患者结果和个性化癌症护理.
持续的研究和临床整合对于实现瘤学多种病的全部潜力至关重要.

关键词:

生物标志物生物标志物早期检测早期检测精确瘤学精确瘤学

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...